Last updated on August 2017

Dose Escalation Study of JNJ-63709178 a Humanized CD123 x CD3 DuoBody in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML)


Brief description of study

The purpose of this study is to characterize the safety and tolerability of JNJ-63709178 and identify the recommended Phase 2 dose(s) (RP2D) and schedule for JNJ-63709178 in Part 1 and to characterize the safety and tolerability of JNJ-63709178 at the RP2D(s) in Part 2.

Detailed Study Description

This is first-in-human (FIH) Phase 1, open-label (identity of assigned study drug will be known), multicenter, dose escalation study with dose expansion to identify the RP2D and to evaluate the safety, tolerability, and preliminary antitumor activity of JNJ-63709178 in adult subjects with relapsed or refractory acute myeloid leukemia (AML) who are ineligible for or have exhausted standard therapeutic options. The study is divided into 3 periods: a Screening Phase (within 28 days before the first dose of study drug), a Treatment Phase (first dose of study drug until the last dose of study drug) and a Post-treatment Follow-up Phase (up to the end of study participation or end of study). Subjects' safety will be monitored throughout the study.

Clinical Study Identifier: NCT02715011

Contact Investigators or Research Sites near you

Start Over

University of Colorado

University of Colorado
Aurora, CO United States
  Connect »

University of Maryland

University of Maryland
Baltimore, MD United States
  Connect »

Barbara Ann Karmanos Cancer Institute

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Use link at the bottom ...

Hackensack University Medical Center
Hackensack, NJ United States
  Connect »

Weill Cornell Medical College / ...

Weill Cornell Medical College / New York Presbyterian Hospital
New York, NY United States
  Connect »

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center
New York, NY United States
  Connect »

University of Rochester

University of Rochester
Rochester, NY United States
  Connect »

Levine Cancer Institute, Carolinas HealthCare ...

Levine Cancer Institute, Carolinas HealthCare System
Charlotte, NC United States
  Connect »

University of Pennsylvania

University of Pennsylvania
Philadelphia, PA United States
  Connect »

University of Pittsburgh Medical Center

University of Pittsburgh Medical Center
Pittsburgh, PA United States
  Connect »

Sarah Cannon Research Institute

Sarah Cannon Research Institute
Nashville, TN United States
  Connect »

University of Texas, MD Anderson ...

University of Texas, MD Anderson Cancer Center
Houston, TX United States
  Connect »

Use link at the bottom ...

Hosp. Univ. Vall D Hebron
Barcelona, Spain
  Connect »

Hosp. Univ. Fund. Jimenez Diaz

Hosp. Univ. Fund. Jimenez Diaz
Madrid, Spain
  Connect »

Use link at the bottom ...

Hosp. Virgen Del Rocio
Sevilla, Spain
  Connect »